FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1946645875> ?p ?o ?g. }

• W1946645875 endingPage "945" @default.
• W1946645875 startingPage "939" @default.
• W1946645875 abstract "Aim Early prediction of (non‐)response to infliximab therapy can improve therapeutic benefit by avoiding unnecessary periods of high disease activity during ineffective therapy. This prospective cohort study therefore aimed to study the predictive value of (1) disease activity alone and (2) infliximab serum trough concentrations in addition to disease activity 6 weeks after start of treatment for achieving low disease activity after 6 months. Methods Disease activity and infliximab serum trough concentrations were assessed in all rheumatoid arthritis ( RA ) patients at 2, 6 and 26 weeks after initiation of infliximab therapy. Receiver operating characteristic ( ROC ) curves and Y ouden indices were used to calculate specificity for prediction of good response after 6 months while aiming for maximum sensitivity. Results Fifty‐seven consecutive RA patients starting with infliximab therapy were included. After 6 months, 15 (26%, 95 % CI 15, 38%) patients reached good European League against Rheumatism ( EULAR ) response. A disease activity score <4.2 at 6 weeks after initiation of therapy was a moderate predictor for reaching EULAR response after 6 months (sensitivity 100%, specificity 49%). Infliximab serum trough concentrations (>2.5 mg l −1 ) as predictor complimentary to disease activity (<4.2) slightly increased the specificity from 49% to 54% without changing the sensitivity (100%). As 39% of the patients did not fulfill at least one of these criteria at week 6, these patients could already be switched to another therapy after 6 weeks. Conclusions The combination of disease activity and infliximab serum trough concentrations could be a fair predictor to identify early (after 6 weeks) patients who have insufficient response after 6 months of therapy." @default.
• W1946645875 created "2016-06-24" @default.
• W1946645875 creator A5029733252 @default.
• W1946645875 creator A5030365370 @default.
• W1946645875 creator A5034989426 @default.
• W1946645875 creator A5055829589 @default.
• W1946645875 creator A5071563219 @default.
• W1946645875 creator A5072002535 @default.
• W1946645875 creator A5075230176 @default.
• W1946645875 creator A5076651742 @default.
• W1946645875 date "2013-11-20" @default.
• W1946645875 modified "2023-10-08" @default.
• W1946645875 title "The combined use of disease activity and infliximab serum trough concentrations for early prediction of (non-)response to infliximab in rheumatoid arthritis" @default.
• W1946645875 cites W1985763670 @default.
• W1946645875 cites W1992628263 @default.
• W1946645875 cites W1994423552 @default.
• W1946645875 cites W1999777294 @default.
• W1946645875 cites W2017883234 @default.
• W1946645875 cites W2103310388 @default.
• W1946645875 cites W2110732019 @default.
• W1946645875 cites W2120989550 @default.
• W1946645875 cites W2122735365 @default.
• W1946645875 cites W2131882149 @default.
• W1946645875 cites W2136624067 @default.
• W1946645875 cites W2141171232 @default.
• W1946645875 cites W2142165059 @default.
• W1946645875 cites W2147165992 @default.
• W1946645875 cites W2152348310 @default.
• W1946645875 cites W2152575748 @default.
• W1946645875 cites W2162370292 @default.
• W1946645875 cites W2166771071 @default.
• W1946645875 cites W2319957449 @default.
• W1946645875 doi "https://doi.org/10.1111/bcp.12142" @default.
• W1946645875 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3845317" @default.
• W1946645875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23601129" @default.
• W1946645875 hasPublicationYear "2013" @default.
• W1946645875 type Work @default.
• W1946645875 sameAs 1946645875 @default.
• W1946645875 citedByCount "31" @default.
• W1946645875 countsByYear W19466458752015 @default.
• W1946645875 countsByYear W19466458752016 @default.
• W1946645875 countsByYear W19466458752017 @default.
• W1946645875 countsByYear W19466458752018 @default.
• W1946645875 countsByYear W19466458752019 @default.
• W1946645875 countsByYear W19466458752020 @default.
• W1946645875 countsByYear W19466458752021 @default.
• W1946645875 countsByYear W19466458752022 @default.
• W1946645875 countsByYear W19466458752023 @default.
• W1946645875 crossrefType "journal-article" @default.
• W1946645875 hasAuthorship W1946645875A5029733252 @default.
• W1946645875 hasAuthorship W1946645875A5030365370 @default.
• W1946645875 hasAuthorship W1946645875A5034989426 @default.
• W1946645875 hasAuthorship W1946645875A5055829589 @default.
• W1946645875 hasAuthorship W1946645875A5071563219 @default.
• W1946645875 hasAuthorship W1946645875A5072002535 @default.
• W1946645875 hasAuthorship W1946645875A5075230176 @default.
• W1946645875 hasAuthorship W1946645875A5076651742 @default.
• W1946645875 hasBestOaLocation W19466458752 @default.
• W1946645875 hasConcept C126322002 @default.
• W1946645875 hasConcept C141071460 @default.
• W1946645875 hasConcept C188816634 @default.
• W1946645875 hasConcept C2777138892 @default.
• W1946645875 hasConcept C2777226972 @default.
• W1946645875 hasConcept C2777489490 @default.
• W1946645875 hasConcept C2777575956 @default.
• W1946645875 hasConcept C2779134260 @default.
• W1946645875 hasConcept C2909675724 @default.
• W1946645875 hasConcept C2911091166 @default.
• W1946645875 hasConcept C31785415 @default.
• W1946645875 hasConcept C71924100 @default.
• W1946645875 hasConcept C90924648 @default.
• W1946645875 hasConceptScore W1946645875C126322002 @default.
• W1946645875 hasConceptScore W1946645875C141071460 @default.
• W1946645875 hasConceptScore W1946645875C188816634 @default.
• W1946645875 hasConceptScore W1946645875C2777138892 @default.
• W1946645875 hasConceptScore W1946645875C2777226972 @default.
• W1946645875 hasConceptScore W1946645875C2777489490 @default.
• W1946645875 hasConceptScore W1946645875C2777575956 @default.
• W1946645875 hasConceptScore W1946645875C2779134260 @default.
• W1946645875 hasConceptScore W1946645875C2909675724 @default.
• W1946645875 hasConceptScore W1946645875C2911091166 @default.
• W1946645875 hasConceptScore W1946645875C31785415 @default.
• W1946645875 hasConceptScore W1946645875C71924100 @default.
• W1946645875 hasConceptScore W1946645875C90924648 @default.
• W1946645875 hasIssue "6" @default.
• W1946645875 hasLocation W19466458751 @default.
• W1946645875 hasLocation W19466458752 @default.
• W1946645875 hasLocation W19466458753 @default.
• W1946645875 hasLocation W19466458754 @default.
• W1946645875 hasOpenAccess W1946645875 @default.
• W1946645875 hasPrimaryLocation W19466458751 @default.
• W1946645875 hasRelatedWork W2058435704 @default.
• W1946645875 hasRelatedWork W2083278471 @default.
• W1946645875 hasRelatedWork W2122265491 @default.
• W1946645875 hasRelatedWork W2125935509 @default.
• W1946645875 hasRelatedWork W2252829258 @default.
• W1946645875 hasRelatedWork W2410231691 @default.
• W1946645875 hasRelatedWork W2560406502 @default.

• next